Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Dexamethasone × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 222 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Recurrence 31 Neoplasms 20 Burkitt Lymphoma 20 Neoplasms, Plasma Cell 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12 Immunoglobulin Light-chain Amyloidosis 11 Neoplasm Metastasis 10 Leukemia 10 Lung Neoplasms 9 Leukemia, Myeloid, Acute 8 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Prostatic Neoplasms 7 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma 6 Leukemia, Biphenotypic, Acute 6 Lymphoma, Non-Hodgkin 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Smoldering Multiple Myeloma 4 Neoplasm, Residual 4 Lymphoma, Mantle-Cell 4 Hodgkin Disease 4 Brain Neoplasms 4 Waldenstrom Macroglobulinemia 3 Vomiting 3 Rectal Neoplasms 3 Plasmacytoma 3

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡